Ind-Swift Labs will disclose their Q4 and FY26 financial results during a board meeting scheduled for May 28, 2026. Details about the trading window closure have already been announced and can be found on their official website.

HCP Investments has disposed of a significant portion (7.5%) of its stake in Ind-Swift Labs by selling 6.5 million shares, aligning with SEBI's Takeover Regulations for increased market transparency.

Ind-Swift Labs attributes the recent surge in trading volume to market dynamics and compliance matters. The arbitration decision with PI Industries has no significant financial impact on Ind-Swift Labs, as stated by the company.

Ind Swift Labs has successfully defended itself in a dispute with PI Industries, as the tribunal ruled in its favor. This decision brings an end to any potential financial implications for Ind Swift.